{"id":"sulopenem-etzadroxil-probenecid","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Sulopenem etzadroxil is a prodrug that is converted into sulopenem, a carbapenem antibiotic that inhibits bacterial cell wall synthesis. Probenecid reduces the reabsorption of sulopenem in the kidneys, increasing its concentration in the urine and allowing for more effective treatment of urinary tract infections.","oneSentence":"Sulopenem etzadroxil/probenecid is a combination antibiotic that works by inhibiting bacterial cell wall synthesis and reducing the reabsorption of the antibiotic in the kidneys.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:36:52.236Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Complicated urinary tract infections (cUTIs), including pyelonephritis"}]},"trialDetails":[{"nctId":"NCT07092813","phase":"PHASE1","title":"Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents","status":"RECRUITING","sponsor":"Iterum Therapeutics, International Limited","startDate":"2026-04","conditions":"Pharmacokinetics After Oral Intake","enrollment":12},{"nctId":"NCT05584657","phase":"PHASE3","title":"Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women","status":"COMPLETED","sponsor":"Iterum Therapeutics, International Limited","startDate":"2022-10-18","conditions":"Urinary Tract Infections, Cystitis","enrollment":2229},{"nctId":"NCT04682834","phase":"","title":"Expanded Access Use of Sulopenem Etzadroxil/Probenecid for Complicated Urinary Tract Infection","status":"NO_LONGER_AVAILABLE","sponsor":"Iterum Therapeutics, International Limited","startDate":"","conditions":"Complicated Urinary Tract Infection, Acute Pyelonephritis","enrollment":""},{"nctId":"NCT04700787","phase":"PHASE1","title":"Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents","status":"WITHDRAWN","sponsor":"Iterum Therapeutics, International Limited","startDate":"2021-04-30","conditions":"Urinary Tract Infections, Pyelonephritis Acute, Intraabdominal Infections","enrollment":""},{"nctId":"NCT03354598","phase":"PHASE3","title":"Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women","status":"COMPLETED","sponsor":"Iterum Therapeutics, International Limited","startDate":"2018-08-01","conditions":"Uncomplicated Urinary Tract Infections","enrollment":1671},{"nctId":"NCT03357614","phase":"PHASE3","title":"Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults","status":"COMPLETED","sponsor":"Iterum Therapeutics, International Limited","startDate":"2018-09-18","conditions":"Complicated Urinary Tract Infections","enrollment":1395},{"nctId":"NCT03358576","phase":"PHASE3","title":"Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)","status":"COMPLETED","sponsor":"Iterum Therapeutics, International Limited","startDate":"2018-09-18","conditions":"Intra Abdominal Infections","enrollment":674}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Individual Patients","Oral sulopenem"],"phase":"phase_3","status":"active","brandName":"Sulopenem Etzadroxil/Probenecid","genericName":"Sulopenem Etzadroxil/Probenecid","companyName":"Iterum Therapeutics, International Limited","companyId":"iterum-therapeutics-international-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sulopenem Etzadroxil/Probenecid is a small molecule that inhibits bacterial penicillin-binding protein. It is being studied for the treatment of various infections, including intra-abdominal infections, complicated urinary tract infections, and urinary tract infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}